Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

1(16.7%)

Early Phase 1

1(16.7%)

6Total

N/A(4)

Phase 4(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06100159Not ApplicableCompleted

Short-term Effects of Ventilation Tubes in Children With Chronic Otitis Media With Effusion

Role: collaborator

NCT06005103Not ApplicableRecruiting

A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression

Role: collaborator

NCT01410409Not ApplicableCompleted

Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement

Role: collaborator

NCT02866305Early Phase 1Unknown

Study Designed to Optimize the Treatment of Primary Pneumothorax

Role: collaborator

NCT01623674Completed

Laparoscopic Skills and Cognitive Function Are Not Affected by Night Shifts in Surgeons

Role: collaborator

NCT01788735Unknown

Unexplained Infertility Among Asthmatic and Atopic Patients

Role: collaborator

NCT01055782Not ApplicableCompleted

Colonoscopy Endoguide in Specialist Practice

Role: collaborator

NCT00851565Phase 4Unknown

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

Role: collaborator

All 8 trials loaded